Sopheon announces that the Company has granted options over 119,000 ordinary shares of 20 pence each in the share capital of the Company (“Options”) to certain directors, executives and senior employees of the Company. Of the directors, Andrew Michuda, CEO and Arif Karimjee, CFO have been granted 50,000 and 15,000 Options respectively, and including this grant, the total number of Options held by each is 290,000 and 85,000 Options respectively.
The Options granted will vest over 3 years, and are exercisable up to 10 years from the date of grant. The exercise price of the Options is 900 pence per share, being the mid-market closing price on AIM on 4 July 2018.
For Further Information Contact:
|Barry Mence, Chairman
Arif Karimjee, CFO
|Sopheon plc||+ 44 (0) 1276 919 560|
|Carl Holmes / Giles Rolls (corporate finance)
Alice Lane (ECM)
|finnCap||+ 44 (0) 20 7220 0500|
Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.